{"id":253,"date":"2023-05-15T17:48:07","date_gmt":"2023-05-15T17:48:07","guid":{"rendered":"https:\/\/demo.themesdaddy.com\/flixita-pro\/?page_id=253"},"modified":"2025-09-24T15:48:43","modified_gmt":"2025-09-24T06:48:43","slug":"page-no-sidebar","status":"publish","type":"page","link":"https:\/\/www.kr-geninus.com\/?page_id=253","title":{"rendered":"CEO’S Message"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n

Company with the best understanding of genes, <\/strong>Geninus Inc.<\/strong><\/em><\/h3>\n

\u00a0<\/p>\n

Dear Valued Customers,<\/strong><\/h4>\n

Thank you sincerely for visiting our website. As the CEO of Geninus Inc., I am delighted to share our vision and goals with you. We are a pioneering company that offers AI-based solutions and data-driven services for cutting-edge clinical research and innovative drug development, grounded in spatial transcriptomics and genomic analysis technologies. Our mission is to accelerate medical innovation through advanced technologies and ultimately enhance the quality of life for patients.<\/p>\n

\n

Our Core Competencies<\/strong><\/h4>\n
    \n
  • \n

    Integrated Spatial Multi-Omics Analysis Platform<\/strong>
    We have developed an advanced platform capable of integrating diverse omics data\u2014such as genomics, transcriptomics, and proteomics. This enables us to gain a comprehensive understanding of complex disease mechanisms and move closer to the realization of personalized medicine.<\/p>\n<\/li>\n

  • \n

    AI-Based Drug Discovery Solutions<\/strong>
    By leveraging artificial intelligence, we are transforming every stage of the drug development process\u2014from target discovery to clinical trial design. This innovation shortens development timelines and increases the probability of success.<\/p>\n<\/li>\n

  • \n

    Integration and Analysis of Clinical Big Data<\/strong>
    In collaboration with various healthcare institutions, we collect and analyze vast amounts of clinical data. This allows us to better understand disease characteristics and contribute to the development of more effective treatments.<\/p>\n<\/li>\n<\/ul>\n

    \n

    Our Vision<\/strong><\/h4>\n

    \u3000Under the vision of “Advancing Medicine Through Innovation,”<\/em> we pursue the following goals:<\/p>\n

      \n
    • \n

      Realization of Precision Medicine:<\/strong>
      Development of personalized therapies based on individual genetic and molecular profiles.<\/p>\n<\/li>\n

    • \n

      Innovation in Drug Development:<\/strong>
      Efficient discovery of new drugs using AI technology.<\/p>\n<\/li>\n

    • \n

      Establishment of a Global Collaborative Network:<\/strong>
      Strengthening strategic partnerships with domestic and international research institutions and pharmaceutical companies.<\/p>\n<\/li>\n<\/ul>\n

      \n

      Our Commitment<\/strong><\/h4>\n

      We are committed to creating social value through ethical and responsible corporate practices. We ensure the highest standards in data security and personal information protection, while guaranteeing transparency and reproducibility in our research outcomes. We deeply appreciate your continued interest and support. Through relentless innovation and unwavering challenges, we promise to contribute to the advancement of global health and the improvement of quality of life (QOL). We look forward to building a better future together.<\/p>\n

      \u00a0<\/p>\n

      \u00a0<\/p>\n

      CEO\u00a0 Woong Yang Park<\/strong><\/em><\/p>\n

      \n
      <\/blockquote>\n<\/blockquote>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

      Company with the best understanding of genes, Geninus Inc. \u00a0 Dear Valued Customers, Thank you sincerely for visiting our website. As the CEO of Geninus Inc., I am delighted to share our vision and goals with you. We are a pioneering company that offers AI-based solutions and data-driven services for cutting-edge clinical research and innovative […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/fullwidth-page.php","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-253","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.kr-geninus.com\/index.php?rest_route=\/wp\/v2\/pages\/253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kr-geninus.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.kr-geninus.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.kr-geninus.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kr-geninus.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=253"}],"version-history":[{"count":20,"href":"https:\/\/www.kr-geninus.com\/index.php?rest_route=\/wp\/v2\/pages\/253\/revisions"}],"predecessor-version":[{"id":1763,"href":"https:\/\/www.kr-geninus.com\/index.php?rest_route=\/wp\/v2\/pages\/253\/revisions\/1763"}],"wp:attachment":[{"href":"https:\/\/www.kr-geninus.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}